Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 16/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.39 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.39 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.39 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | BRAF | P15056 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | GCGR | P47871 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7494396 | 0.88 | MAPK14 (0.44) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7495111 | 0.85 | MAPK14 (0.45) | ALOX5MAPK14KCNH2MAPK11CSNK1A1 | |
| SCHEMBL7496496 | 0.84 | MAPK14 (0.48) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7488387 | 0.84 | MAPK14 (0.48) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7492768 | 0.83 | MAPK14 (0.49) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| Hydrochloric Acid SCHEMBL7495189 | 0.83 | MAPK14 (0.48) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7491594 | 0.83 | MAPK14 (0.43) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7491641 | 0.83 | MAPK14 (0.43) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7492880 | 0.83 | MAPK14 (0.43) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D | |
| SCHEMBL7498076 | 0.83 | MAPK14 (0.43) | MAPK14KCNH2MAPK11CSNK1A1CSNK1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0686156-B1 | PYRAZOLITRIAZINES WITH INTERLEUKIN-1 AND TUMOUR NECROSIS FACTOR INHIBITORY ACTIVITY | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-07-17 | — | — | EP | disclosed |
| EP-0686156-A1 | PYRAZOLITRIAZINES WITH INTERLEUKIN-1 AND TUMOUR NECROSIS FACTOR INHIBITORY ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-13 | — | — | EP | disclosed |
| WO-1994019350-A1 | PYRAZOLITRIAZINES WITH INTERLEUKIN-1 AND TUMOUR NECROSIS FACTOR INHIBITORY ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-01 | — | — | WO | disclosed |